FdaApplication
ANDA 210391
Identifiers
- fda_app_no: ANDA210391
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LIMITED |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE | ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE | 300MG | TABLET |
| ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE | ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE | 50MG | TABLET |
2 products